Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union

Regulatory Toxicology and Pharmacology

Volumn 55, Issue 2, 2009, Pages 111-122

  Beronius, Anna ^a   Rudén, Christina ^b   Hanberg, Annika ^a   Håkansson, Helen ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Chemical safety; Chemicals legislation; Endocrine disruptor; Risk assessment; Test requirements

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DIOXIN; ENDOCRINE DISRUPTOR; VINCLOZOLIN;

ACUTE TOXICITY; ARTICLE; CARCINOGENICITY; CHRONIC TOXICITY; CONTROLLED STUDY; EUROPEAN UNION; FOOD CONTAMINATION; FOOD SAFETY; GENOTOXICITY; GOVERNMENT REGULATION; HEALTH HAZARD; MUTAGENICITY; NEUROTOXICITY; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SKIN SENSITIZATION; TOXICITY TESTING; TOXICOKINETICS;

AGROCHEMICALS; ANIMALS; ENDOCRINE DISRUPTORS; ENDOCRINE SYSTEM; ENVIRONMENTAL EXPOSURE; EUROPEAN UNION; FOOD CONTAMINATION; FOOD SUPPLY; GOVERNMENT REGULATION; HUMANS; INDUSTRY; RISK ASSESSMENT; TOXICITY TESTS;

ANIMALIA;

EID: 70349499025     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2009.05.019     Document Type: Article

References (47)

1. Barlow S.M. Dilemmas facing regulatory and advisory bodies dealing with conflicting results. Chemosphere 39 (1999) 1287-1292
2. Colbert N.K.W., Pelletier N.C., Cote J.M., Concannon J.B., Jurdak N.A., Minott S.B., and Markowski V.P. Perinatal exposure to low levels of the environmental antiandrogen vinclozolin alters sex-differentiated social play and sexual behaviours in the rat. Environ. Health Perspect. 113 (2005) 700-707
3. Commission Directive 2003/63/EC of 25 June 2003 amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use. Official Journal of the Communities L 159, 27/06/2003, pp. 0046-0094.
4. Commission Directive 93/71/EEC of 27 July 1993 amending Council Directive 91/414/EEC concerning the placing of plant protection products on the market. Official Journal of the Communities L 221, 31/08/1993, pp. 0027-0036.
5. Commission Directive 94/79/EC of 21 December 1994 amending Council Directive 91/414/EEC concerning the placing of plant protection products on the market. Official Journal of the Communities L 354, 31/12/1994, pp. 0016-0031.
6. Commission Regulation (EC) No. 1488/94 of 28 June 1994 laying down the principles for the assessment of risks to man and the environment of existing substances in accordance with Council Regulation (EEC) No. 793/93. Official Journal of the Communities L 161, 29/06/1994, pp. 0003-0011.
7. Commission Regulation (EEC) No. 3600/92 of 11 December 1992 laying down the detailed rules for the implementation of the first stage of the programme of work referred to in Article 8 (2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market. Official Journal of the Communities L 366, 15/12/1992, pp. 0010-0016.
8. Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Official Journal of the Communities 196, 16/08/1967, pp. 0001-0098.
9. Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. Official Journal L 230, 19/08/1991, pp. 0001-0032.
10. Council Directive 97/57/EC of 22 September 1997 establishing Annex VI to Directive 91/414/EEC concerning the placing of plant protection products on the market. Official Journal of the Communities L 265, 27/09/1997, pp. 0087-0109.
11. Council Regulation (EEC) No. 793/93 of 23 March 1993 on the evaluation and control of the risks of existing substances. Official Journal of the Communities L 084, 05/04/1993, pp. 0001-0075.
12. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal of the Communities L 311, 28/11/2001, pp. 0067-0128.
13. Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the Communities L 136, 30/04/2004, pp. 0034-0057.
14. EC, 1997. European Commission Peer Review Programme, ECCO meetings, Vinclozolin, vol. 3 Annex B.
15. EC, 1998a. European Commission Peer Review Programme, ECCO meetings, Vinclozolin, Addendum to EC, 1997 - toxicology and metabolism.
16. EC, 1998b. Guidelines and criteria for the evaluation of dossiers and for the preparation of reports to the European Commission by Rapporteur Member States relating to the proposed inclusion of active substances in Annex I of Directive 91/414/EEC. Available from: .
17. ECB, 2003. Technical guidance document on risk assessment, Part I. Available from: .
18. EFSA, 2006. Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission related to 2,2-bis(4-hydroxyphenyl)propane (Bisphenol A). Available from: .
19. EMEA, 2003a. CPMP/ICH/2887/99 Common technical document for the registration of pharmaceuticals for human use - Safety. Available from: .
20. EMEA, 2003b. CPMP/ICH/2887/99 Common technical document for the registration of pharmaceuticals for human use - Efficiacy. Available from: .
21. EMEA, 2005. CPMP/SWP/799/95 Guideline on the non-clinical documentation for mixed marketing authorisation applications. Available from: .
22. EMEA, 2008a. CHMP/ICH/126642/2008 Note for guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use - draft. Available from: www.emea.europa.eu/.
23. EMEA, 2008b. CHMP/203927/2005 Guideline on risk assessment of medicinal products on human reproduction and lactation: from data to labelling. Available from: .
24. EU, 2003. Bisphenol-A: European Union Risk Assessment Report (CAS No. 80-05-7). Available from: .
25. Faqi A.S., Dalsenter P.R., Merker H.-J., and Chahoud I. Reproductive toxicity and tissue concentrations of low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male offspring rats exposed throughout pregnancy and lactation. Toxicol. Appl. Pharmacol. 150 (1998) 383-392
26. Gray Jr. L.E., Ostby J.S., and Kelce W.R. A dose-response analysis of the reproductive effects of a single gestational dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male Long Evans hooded rat offspring. Toxicol. Appl. Pharmacol. 146 (1997) 11-20
27. Gupta C. Reproductive malformation of the male offspring following maternal exposure to estrogenic chemicals. PSEBM 224 (2000) 61-68
28. IPCS, 2002. Global assessment of the state-of-the-science of endocrine disruptors. In: Terri Dmastra, Sue Barlow, Aake Bergman, Robert Kavlock, Glen van der Kraak (Eds.). Available from: .
29. Kelce W.R., Monosson E., Gamcsik M.P., Laews S.C., and Gray Jr. L.E. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by androgenic metabolites. Toxicol. Appl. Pharmacol. 126 (1994) 276-285
30. Mably T.A., Moore R.W., and Peterson R.E. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 3. Effects on spermatogenesis and reproductive capability. Toxicol. Appl. Pharmacol. 114 (1992) 118-126
31. Matthews J.B., Twomey K., and Zacharewski T.R. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors α and β. Chem. Res. Toxicol. 14 (2001) 149-157
32. NTP, 2001. The National Toxicology Program's Report of the Endocrine Disruptors Low Dose Peer Review. Available from: .
33. Ohsako S., Miyabara Y., Nishimura N., Kurosawa S., Sakaue M., Ishimura R., Sato M., Takeda K., Aoki Y., Sone H., Tohyama C., and Yonemoto J. Maternal exposure to a low dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppressed the development of reproductive organs of male rats: dose-dependent increase of mRNA levels of 5α-reductase type 2 in contrast to decrease of androgen receptor in the pubertal ventral prostate. Toxicol. Sci. 60 (2001) 132-143
34. Regulation (EC) No. 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. Official Journal of the Communities L 31, 1/2/2002, pp. 1-24.
35. Regulation (EC) No. 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. Official Journal of the Communities L 136, 30/04/2004, pp. 0001-0033.
36. Rubin B.S., Murray M.K., Damassa D.A., King J.C., and Soto A.M. Perinatal exposure to low doses of Bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. 109 (2001) 675-680
37. SCF, 2000. Opinion of the Scientific Committee on Food on the risk assessment of dioxins and dioxin-like PCBs in food. Available from: .
38. SCF, 2001. Opinion of the Scientific Committee on Food on the risk assessment of dioxins and dioxin-like PCBs in food. Up-date based on new scientific information. Available from: .
39. Sheehan D.M., Willingham E., Gaylor D., Bergeron J.M., and Crews D. No threshold for estradiol-induced sex reversal of turtle embryos: how little is too much?. Environ. Health Perspect. 107 (1999) 155-159
40. Sheehan D.M. Activity of environmentally low doses of endocrine disruptors and the bisphenol-A controversy: initial results confirmed. Proc. Soc. Exp. Biol. Med. 224 (2000) 57-60
41. Timms B.G., Howdeshell K.L., Barton L., Bradley S., Richter C.A., and vom Saal F.S. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. PNAS 102 (2005) 7014-7019
42. Tyl R.W., Myers C.B., Marr M.C., Thomas B.F., Keimowitz A.R., Brine D.R., Veselica M.M., Fail P.A., Chang T.Y., Seely J.C., Joiner R.L., Butala J.H., Dimond S.S., Cagen S.Z., Shiotsuka R.N., Stropp G.D., and Waechter J.M. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxciol. Sci. 68 (2002) 121-146
43. Tyl R.W., Myers C.B., Marr M.C., Sloan C.S., Castillo N.P., Veselica M.M., Seely J.C., Dimond S.S., Van Miller J.P., Shiotsuka R.N., Beyer D., Hentges S.G., and Waechter Jr. J.M. Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol. Sci. 104 (2008) 362-384
44. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., Vandenbergh J.G., Walser-Kuntz D.R., and vom Saal F.S. In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 24 (2007) 199-224
45. Veeramachaneni D.N., Palmer J.S., Amann R.P., Kane C.M., Higuchi T.T., and Pau K.Y. Disruption of sexual function, FSH secretion, and spermiogenesis in rabbits following developmental exposure to vinclozolin, a fungicide. Reproduction 131 (2006) 805-816
46. vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., Dhar M.D., Ganjam V.K., Parmigiani S., and Welshons W.V. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc. Natl. Acad. Sci. 94 (1997) 2056-2061
47. Wetherill Y.B., Akingbemi B.T., Kanno J., McLachlan J.A., Nadal A., Sonnenschein C., Watson C.S., Zoeller R.T., and Belcher S.M. In vitro molecular mechanisms of bisphenol A action. Reprod. Toxicol. 24 (2007) 178-198